Full Press Release Details
SANUWAVE ANNOUNCES STRATEGIC PARTNERSHIP WITH PREMIER
DERMAPACE ENTERS VA, INDIAN HEALTH SERVICES, AND MILITARY BASE
REVENUES EXPECTED TO OCCUR IMMEDIATELY
SUWANEE, GA, FEBRUARY 13, 2018 - SANUWAVE Health, Inc. (OTCQB:
SNWV) is pleased to announce a partnership agreement has
been reached with Premier Shockwave Wound Care, Inc. and Premier
Shockwave, Inc. (collectively Premier ). The agreement
will cover the Veteran's Administration (VA), Indian Health
Service (IHS) and Tribally operated healthcare services, and US
Military facilities/bases (MTFs). Per the agreement, Premier will
purchase an undisclosed number of dermaPACE units to service these
end markets and SANUWAVE will receive revenue from the sale of the
equipment and a per procedure fee from Premier. The contract
includes a minimum purchase of 100 units over 3 years and is
expected to provide a high margin, recurring revenue as Premier
rolls out its services. This agreement allows SANUWAVE to enter the
market immediately thereby accelerating revenue growth by
targeted market for this strategic partnership is a large market.
The population of the VA and IHS markets combined is roughly 24
million people with 4 million having complications from diabetes.
These constituents are served through health care systems which are
made up of: 170 VA hospitals, 1,063 outpatient sites, 45 IHS/Tribal
hospitals, 343 health centers, 111 health stations, and 163 village
clinics in Alaska for a total of 2,295 locations. Premier plans to
roll the device placements out to the top locations in 2018, with
an accelerated ramp up through 2020.
are extremely pleased to announce our partnership with Premier.
They bring to the table an understanding of both shock wave
technology and government contracting. This agreement allows us to
enter an underserved market immediately and begin rapidly
introducing dermaPACE System into the US market as a whole,
said Kevin A. Richardson II, Chief Executive Officer of SANUWAVE.
Our growth plan is to develop channel partners, like this
one, put in place proper financing to fund product placement, and
to work with Key Opinion Leaders to have the clinical support
needed to further penetrate all US wound markets while having a
strong reimbursement platform in place. This is one more step in
executing our plan for success at SANUWAVE. The goal is to increase market segment
by continuing to make healthcare professionals and clinicians aware
of this technology as an option in their treatment
(ret) Patrick Sesto, DPM, Medical Advisor to SANUWAVE said,
dermaPACE will revolutionize the treatment of diabetic foot
ulcers. This is the first time a treatment modality has
dramatically reduced the time to wound closure and decreased costs to the payer. The
dermaPACE treatment application is straight-forward enough that the
physician can have their wound care nurse or technician provide the
treatment, freeing the physician to see other patients. The
promotion of circulation on a micro-vascular level coupled with the
releasing of essential growth factors lays down a foundation for
the wound to heal. In my 33-years of practice both civilian and
military, I have never seen such remarkable progress with these
types of ulcers. It will decrease dramatically the morbidity that
leads to amputation and thereby afford the patient a higher quality
We are proud to be able to serve the Indian Health Services
and the Veterans Administration and ensure that both Native
American Indians and Alaska Natives, as well as our country's
Veterans receive the latest and most advanced technology available
to treat and cure diabetic foot ulcers, said A. Michael
Stolarski, President and CEO of Premier Shockwave, Inc., the
Manager Partner. The IHS and VA patient demographics are
quite similar in that about 16-17% of this population suffers from
diabetes mellitus (DM), and 3-4% of those with DM develop one or
more diabetic foot ulcers (DFUs) each year. In addition, the
amputation rate of these individuals is typically higher than the
Jim Clare, COO of Premier Shockwave added, Premier Shockwave
is looking forward to working with the IHS Special Diabetes Program
for Indians (SDPI) and the VA's Prevention of Amputations in
Veterans Everywhere (PAVE) program. Mr. Clare added,
As the FDA study shows, the dermaPACE will materially reduce
the incidence of amputation and speed wound healing in the majority
of patients receiving treatment. The treatment can be conveniently
performed when the patient is receiving weekly wound dressing
changes. We believe the dermaPACE will prove to be significantly
more cost effective than other treatments for chronic diabetic foot
David Anderson, Executive Vice President of Premier Shockwave Wound
Care, Inc. adds, Treating chronic diabetic foot ulcers
usually requires a multi-pronged attack. The use of the dermaPACE
System will enable the IHS to treat more patients in-house,
decrease the number of amputations, and increase quality of life
for those DFU patients. The late John Ferris, MD, and Chief Medical
Officer for the Oklahoma City area Indian Health Service once told
me, we (IHS) are paying between $17,000 to $22,000 per
patient to outsource DFUs.' The dermaPACE is a game changer
and should save the IHS many millions of
Mr. Stolarski added, We have filed paperwork with the VA to
get on the Government Services Administration (GSA) Schedule, which
should be completed within the next 4-6 months; however, in the
meantime, we are confident in our ability to place devices and
receive payment for dermaPACE services at IHS, VA and
About SANUWAVE Health, Inc.
Health, Inc. (OTCQB:SNWV) (www.sanuwave.com)
is a shock wave technology company initially focused on the
development and commercialization of patented noninvasive,
biological response activating devices for the repair and
regeneration of skin, musculoskeletal tissue and vascular
structures. SANUWAVE's portfolio of regenerative medicine
products and product candidates activate biologic signaling and
angiogenic responses, producing new vascularization and
microcirculatory improvement, which helps restore the body's
normal healing processes and regeneration. SANUWAVE applies its